Previous work in our laboratory showed that reducing Ins1 gene dosage (on an Ins2-null background) resulted in continuous suppression of fasting hyperinsulinemia in male mice, thereby preventing diet-induced obesity [14]. This evidence concerns the gene FOXM1 and obesity due to melanocortin 4 receptor deficiency.